Skip to content

Author

Y. Meng

We have 1 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world effectiveness of first-line chemoimmunotherapy versus chemotherapy in older adults with extensive-stage small cell lung cancer: an inverse probability treatment weighted analysis.

Comparison evidence of improved survival in association with ICI-chemo compared with chemo in older adults with ES-SCLC is provided, providing comparative evidence of improved survival in association with ICI-chemo.

Si-Yuan Cui, Kui Zhao, Na Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.